Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Zebra 365 who wrote (9955)	6/23/1998 7:41:00 PM
From: Cacaito	Respond to of 23519

Zebra: "Results are less promising in Steers' as-yet-unpublished study of 1,418 men with the most "severe" impotence. Of those who took 50 or 100 milligrams of Viagra for eight weeks, only 46 percent were able to have intercourse at least "most of the time." For the placebo, the success rate was 8 percent." This Steers study are stronger for Viagra than the original ones from Pfizer. Here is 46% viagra vs 8% placebo. Question: Does anybody knows how the "severe" Steers patients were screen, at least the placebo effect is saying that the placebo group was a very poor performance group. Well, at least is leaving some 54% of patients to try Muse. still long, cacaito